At a glance
- Originator Pfizer
- Class Anti-ischaemics; Dihydropyridines; Heart failure therapies; Small molecules
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Ischaemic heart disorders
Most Recent Events
- 08 Nov 2000 Discontinued - Preclinical for Heart failure in USA
- 08 Nov 2000 Discontinued - Preclinical for Ischaemic heart disorders in USA